ConductScience.org, home

Trial · NCT06556277

Registered outcomes50

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTotal body fatTwo 7-day intervention periodsChange in total body fat assessed with a Dual-Energy-X-Ray-Absorptiometry (DXA)
SecondaryTotal lean massTwo 7-day intervention periodsChange in total lean mass assessed with DXA
SecondaryInsulin sensitivityTwo 7-day intervention periodsChange in insulin sensitivity assessed with a mixed meal tolerance test
SecondaryGlucoseTwo 7-day intervention periodsChange in Glucose assessed with a mixed meal tolerance test
SecondaryInsulinTwo 7-day intervention periodsChange in Insulin assessed with a mixed meal tolerance test
SecondaryC-peptideTwo 7-day intervention periodsChange in C-peptide assessed with a mixed meal tolerance test
SecondaryEnergy expenditureTwo 7-day intervention periodsBasal metabolic rate measured with indirect calorimetryy
SecondarySubstrate utilizationTwo 7-day intervention periodsRespiratory quotient assessed with indirect calorimetry
SecondarySystolic and diastolic blood pressureTwo 7-day intervention periodsAssessment of blood pressure with a standard blood pressure monitor.
SecondaryWeightTwo 7-day intervention periodsMeasurement of weight with a standard scale
SecondaryLipids (mmol/l) ((total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides)Two 7-day intervention periodsBlood sample
SecondaryImmune cells (peripheral blood mononuclear cells)Two 7-day intervention periodsBlood sample
SecondarySatiationTwo 7-day intervention periodsAmount of food intake with ad libitum buffet
SecondarySatietyTwo 7-day intervention periodsAppetite rating with visual analogue scale (VAS) from 0mm-100mm (0mm=not at all and 100mm=extreme)
SecondaryMotivationTwo 7-day intervention periodsMotivation to eat measured with a speed clicking test
SecondaryIL-6 (Inflammatory markers)Two 7-day intervention periodsBlood sample
SecondaryIL-1RA (Inflammatory markers)Two 7-day intervention periodsBlood sample
SecondaryIL-8 (Inflammatory markers)Two 7-day intervention periodsBlood sample
SecondaryCRP (Inflammatory markers)Two 7-day intervention periodsBlood sample
SecondaryThyroid hormonesTwo 7-day intervention periodsBlood sample

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06556277/registered